|
1
|
Han IB, Kim OJ, Ropper AE, Kim HS, Cho YK,
Teng YD and Kim NK: Association between kinase insert
domain-containing receptor gene polymorphisms and silent brain
infarction: a Korean study. J Neurol Sci. 318:85–89. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song J, Kim OJ, Kim HS, Bae SJ, Hong SP,
Oh D and Kim NK: Endothelial nitric oxide synthase gene
polymorphisms and the risk of silent brain infarction. Int J Mol
Med. 25:819–823. 2010.PubMed/NCBI
|
|
3
|
Kobayashi S, Okada K, Koide H, Bokura H
and Yamaguchi S: Subcortical silent brain infarction as a risk
factor for clinical stroke. Stroke. 28:1932–1939. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuller LH, Shemanski L, Manolio T, Haan M,
Fried L, Bryan N, Burke GL, Tracy R and Bhadelia R: Relationship
between ApoE, MRI findings, and cognitive function in the
Cardiovascular Health Study. Stroke. 29:388–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barber R, Scheltens P, Gholkar A, Ballard
C, McKeith I, Ince P, Perry R and O’Brien J: White matter lesions
on magnetic resonance imaging in dementia with Lewy bodies,
Alzheimer’s disease, vascular dementia, and normal aging. J Neurol
Neurosurg Psychiatry. 67:66–72. 1999.
|
|
6
|
Vermeer SE, Koudstaal PJ, Oudkerk M,
Hofman A and Breteler MM: Prevalence and risk factors of silent
brain infarcts in the population-based Rotterdam Scan Study.
Stroke. 33:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vermeer SE, Hollander M, van Dijk EJ,
Hofman A, Koudstaal PJ and Breteler MM; Rotterdam Scan Study.
Silent brain infarcts and white matter lesions increase stroke risk
in the general population: the Rotterdam Scan Study. Stroke.
34:1126–1129. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsui T, Arai H, Yuzuriha T, Yao H, Miura
M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A and
Sasaki H: Elevated plasma homocysteine levels and risk of silent
brain infarction in elderly people. Stroke. 32:1116–1119. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim NK, Choi BO, Jung WS, Choi YJ and Choi
KG: Hyperhomocysteinemia as an independent risk factor for silent
brain infarction. Neurology. 61:1595–1599. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eguchi K, Kario K, Hoshide S, Hoshide Y,
Ishikawa J, Morinari M, Hashimoto T and Shimada K: Smoking is
associated with silent cerebrovascular disease in a high-risk
Japanese community-dwelling population. Hypertens Res. 27:747–754.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH
and Yoon BW: Metabolic syndrome as an independent risk factor of
silent brain infarction in healthy people. Stroke. 37:466–470.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oh SH, Min KT, Jeon YJ, Kim MH, Kim OJ,
Shin BS, Oh D and Kim NK: Association between common genetic
variants of α2A-, α2B-, and α2C-adrenergic receptors and ischemic
stroke. Clin Neurol Neurosurg. 115:26–31. 2013.
|
|
13
|
MacDonald E, Kobilka BK and Scheinin M:
Gene targeting - homing in on alpha 2-adrenoceptor-subtype
function. Trends Pharmacol Sci. 18:211–219. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lockette W, Ghosh S, Farrow S, MacKenzie
S, Baker S, Miles P, Schork A and Cadaret L: Alpha 2-adrenergic
receptor gene polymorphism and hypertension in blacks. Am J
Hypertens. 8:390–394. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rosengren AH, Jokubka R, Tojjar D,
Granhall C, Hansson O, Li DQ, Nagaraj V, Reinbothe TM, Tuncel J,
Eliasson L, Groop L, Rorsman P, Salehi A, Lyssenko V, Luthman H and
Renström E: Overexpression of alpha2A-adrenergic receptors
contributes to type 2 diabetes. Science. 327:217–220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobilka BK, Matsui H, Kobilka TS,
Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ and Regan JW:
Cloning, sequencing, and expression of the gene coding for the
human platelet alpha 2-adrenergic receptor. Science. 238:650–656.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Small KM, Wagoner LE, Levin AM, Kardia SL
and Liggett SB: Synergistic polymorphisms of beta1-and
alpha2C-adrenergic receptor and the risk of congestive heart
failure. N Engl J Med. 347:1135–1142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim OJ, Lee JH, Choi JK, Oh SH, Hong SH,
Oh D and Kim NK: Association between tumor necrosis factor-alpha
(-308G→A and -238G→A) polymorphisms and homocysteine levels in
patients with ischemic strokes and silent brain infarctions.
Cerebrovasc Dis. 30:483–490. 2010.
|
|
19
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J R Statist Soc B. 57:289–300. 1995.
|
|
20
|
Avery RA, Franowicz JS, Studholme C, van
Dyck CH and Arnsten AF: The alpha-2A-adrenoceptor agonist,
guanfacine, increases regional cerebral blood flow in dorsolateral
prefrontal cortex of monkeys performing a spatial working memory
task. Neuropsychopharmacology. 23:240–249. 2000. View Article : Google Scholar
|
|
21
|
Willems EW, Valdivia LF, Villalón CM and
Saxena PR: Possible role of alpha-adrenoceptor subtypes in acute
migraine therapy. Cephalalgia. 23:245–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaya S, Kolodjaschna J, Berisha F, Polska
E, Pemp B, Garhöfer G and Schmetterer L: Effect of the
α(2)-adrenoceptor antagonist yohimbine on vascular regulation of
the middle cerebral artery and the ophthalmic artery in healthy
subjects. Microvasc Res. 81:117–122. 2011.
|
|
23
|
Neumeister A, Charney DS, Belfer I, Geraci
M, Holmes C, Sharabi Y, Alim T, Bonne O, Luckenbaugh DA, Manji H,
Goldman D and Goldstein DS: Sympathoneural and adrenomedullary
functional effects of alpha2C-adrenoreceptor gene polymorphism in
healthy humans. Pharmacogenet Genomics. 15:143–149. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chotani MA, Mitra S, Su BY, Flavahan S,
Eid AH, Clark KR, Montague CR, Paris H, Handy DE and Flavahan NA:
Regulation of alpha(2)-adrenoceptors in human vascular smooth
muscle cells. Am J Physiol Heart Circ Physiol. 286:H59–H67. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Small KM, Brown KM, Forbes SL and Liggett
SB: Polymorphic deletion of three intracellular acidic residues of
the alpha 2B-adrenergic receptor decreases G protein-coupled
receptor kinase-mediated phosphorylation and desensitization. J
Biol Chem. 276:4917–4922. 2001. View Article : Google Scholar
|
|
26
|
Snapir A, Heinonen P, Tuomainen TP,
Alhopuro P, Karvonen MK, Lakka TA, Nyyssönen K, Salonen R, Kauhanen
J, Valkonen VP, Pesonen U, Koulu M, Scheinin M and Salonen JT: An
insertion/deletion polymorphism in the alpha2b-adrenergic receptor
gene is a novel genetic risk factor for acute coronary events. J Am
Coll Cardiol. 37:1516–1522. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Snapir A, Mikkelsson J, Perola M, Penttilä
A, Scheinin M and Karhunen PJ: Variation in the
alpha2B-adrenoceptor gene as a risk factor for prehospital fatal
myocardial infarction and sudden cardiac death. J Am Coll Cardiol.
41:190–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Small KM, Forbes SL, Rahman FF, Bridges KM
and Liggett SB: A four amino acid deletion polymorphism in the
third intracellular loop of the human alpha 2C-adrenergic receptor
confers impaired coupling to multiple effectors. J Biol Chem.
275:23059–23064. 2000. View Article : Google Scholar
|
